Mariya Markova

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association

High‐protein diet more effectively reduces hepatic fat than low‐protein diet despite lower autophagy and FGF21 levels

Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes